Evidence map›Paper›PMID 26819684›Full record

ArticleJournal of Korean Neurosurgical Society2015

Neuroprotective Effect of Resveratrol on Acute Brain Ischemia Reperfusion Injury by Measuring Annexin V, p53, Bcl-2 Levels in Rats.

Ceren Kizmazoglu, Hasan Emre Aydin, Ismail Ertan Sevin, Orhan Kalemci, Nurullah Yüceer, Metin Ant Atasoy

Abstract read
In one paragraph

Article in Journal of Korean Neurosurgical Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Resveratrol: Protective Agent Against Alzheimer's Disease.Central nervous system agents in medicinal chemistry · 2024
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Nutritional Regulators of Bcl-xL in the Brain.Molecules (Basel, Switzerland) · 2018
    Review
  13. Cerebral ischemia and neuroregeneration.Neural regeneration research · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ceren KizmazogluDepartment of Neurosurgery, Katip Celebi University Izmir Atatürk Training and Research Hospital, Izmir, Turkey.
Hasan Emre AydinDepartment of Neurosurgery, Eskisehir State Hospital, Eskisehir, Turkey.; Department of Pharmacology, Eskişehir Osmangazi University, Eskisehir, Turkey.
Ismail Ertan SevinDepartment of Neurosurgery, Katip Celebi University Izmir Atatürk Training and Research Hospital, Izmir, Turkey.
Orhan KalemciDepartment of Neurosurgery, Dokuz Eylul University, School of Medicine Hospital, Izmir, Turkey.
Nurullah YüceerDepartment of Neurosurgery, Katip Celebi University Izmir Atatürk Training and Research Hospital, Izmir, Turkey.
Metin Ant AtasoyDepartment of Neurosurgery, Eskişehir Osmangazi University School of Medicine Hospital, Eskisehir, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCerebral ischemia is as a result of insufficient cerebral blood flow for cerebral metabolic functions. Resveratrol is a natural phytoalexin that can be extracted from grape's skin and had potent role in treating the cerebral ischemia. Apoptosis, a genetically programmed cellular event which occurs after ischemia and leads to biochemical and morphological changes in cells. There are some useful markers for apoptosis like Bcl-2, bax, and p53. The last reports, researchers verify the apoptosis with early markers like Annexin V.

methodsWe preferred in this experimental study a model of global cerebral infarction which was induced by bilateral common carotid artery occlusion method. Rats were randomly divided into 4 groups : sham, ischemia-reperfusion (I/R), I/R plus 20 mg/kg resveratrol and I/R plus 40 mg/kg resveratrol. Statistical analysis was performed using Sigmastat 3.5 ve IBM SPSS Statistics 20. We considered a result significant when p<0.001.

resultsAfter administration of resveratrol, Bcl-2 and Annexin levels were significantly increased (p<0.001). Depending on the dose of resveratrol, Bcl2 levels increased, p53 levels decreased but Annexin V did not effected. P53 levels were significantly increased in ishemia group, so apoptosis is higher compared to other groups.

conclusionIn the acute period, Annexin V levels misleading us because the apoptotic cell counts could not reach a certain level. Therefore we should support our results with bcl-2 and p53.

Indexed as

Annexin VBcl-2Brain Ischemiap53Resveratrol

Identifiers

PMID26819684
PMCPMC4728087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.